179 related articles for article (PubMed ID: 16397256)
1. Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.
Kassouf W; Chintharlapalli S; Abdelrahim M; Nelkin G; Safe S; Kamat AM
Cancer Res; 2006 Jan; 66(1):412-8. PubMed ID: 16397256
[TBL] [Abstract][Full Text] [Related]
2. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
Chintharlapalli S; Smith R; Samudio I; Zhang W; Safe S
Cancer Res; 2004 Sep; 64(17):5994-6001. PubMed ID: 15342379
[TBL] [Abstract][Full Text] [Related]
3. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
York M; Abdelrahim M; Chintharlapalli S; Lucero SD; Safe S
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6743-52. PubMed ID: 18006776
[TBL] [Abstract][Full Text] [Related]
4. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
Chintharlapalli S; Papineni S; Baek SJ; Liu S; Safe S
Mol Pharmacol; 2005 Dec; 68(6):1782-92. PubMed ID: 16155208
[TBL] [Abstract][Full Text] [Related]
5. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.
Chintharlapalli S; Papineni S; Safe S
Mol Pharmacol; 2007 Feb; 71(2):558-69. PubMed ID: 17093136
[TBL] [Abstract][Full Text] [Related]
6. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects.
Calabrò P; Samudio I; Safe SH; Willerson JT; Yeh ET
J Vasc Res; 2005; 42(6):509-16. PubMed ID: 16155367
[TBL] [Abstract][Full Text] [Related]
8. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
Chintharlapalli S; Papineni S; Safe S
Mol Cancer Ther; 2006 May; 5(5):1362-70. PubMed ID: 16731770
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.
Hong J; Samudio I; Liu S; Abdelrahim M; Safe S
Endocrinology; 2004 Dec; 145(12):5774-85. PubMed ID: 15345676
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
[TBL] [Abstract][Full Text] [Related]
11. Bacillus Calmette-Guérin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells.
Lodillinsky C; Umerez MS; Jasnis MA; Casabé A; Sandes E; Eiján AM
Int J Mol Med; 2006 Feb; 17(2):269-73. PubMed ID: 16391825
[TBL] [Abstract][Full Text] [Related]
12. 3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5.
Abdelrahim M; Newman K; Vanderlaag K; Samudio I; Safe S
Carcinogenesis; 2006 Apr; 27(4):717-28. PubMed ID: 16332727
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma-dependent activity of indole ring-substituted 1,1-bis(3'-indolyl)-1-(p-biphenyl)methanes in cancer cells.
Guo J; Chintharlapalli S; Lee SO; Cho SD; Lei P; Papineni S; Safe S
Cancer Chemother Pharmacol; 2010 May; 66(1):141-50. PubMed ID: 19823826
[TBL] [Abstract][Full Text] [Related]
14. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways.
Lei P; Abdelrahim M; Safe S
Mol Cancer Ther; 2006 Sep; 5(9):2324-36. PubMed ID: 16985067
[TBL] [Abstract][Full Text] [Related]
15. Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.
Cho SD; Yoon K; Chintharlapalli S; Abdelrahim M; Lei P; Hamilton S; Khan S; Ramaiah SK; Safe S
Cancer Res; 2007 Jan; 67(2):674-83. PubMed ID: 17234778
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
Shiau CW; Yang CC; Kulp SK; Chen KF; Chen CS; Huang JW; Chen CS
Cancer Res; 2005 Feb; 65(4):1561-9. PubMed ID: 15735046
[TBL] [Abstract][Full Text] [Related]
17. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
18. 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
Chintharlapalli S; Papineni S; Liu S; Jutooru I; Chadalapaka G; Cho SD; Murthy RS; You Y; Safe S
Carcinogenesis; 2007 Nov; 28(11):2337-46. PubMed ID: 17724373
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
[TBL] [Abstract][Full Text] [Related]
20. Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer.
Inamoto T; Shah JB; Kamat AM
Urol Oncol; 2009; 27(6):585-91. PubMed ID: 19162510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
